Clinical Research Directory
Browse clinical research sites, groups, and studies.
Surveys, Blood Testing, and Fibroscan in Screening for Liver Fibrosis and Liver Cirrhosis
Sponsor: M.D. Anderson Cancer Center
Summary
This clinical trial studies the use of surveys, blood testing, and fibroscan in screening for liver fibrosis and liver cirrhosis in new or existing patients of the HOPE clinic seeking usual clinical care. Fibroscan is an imaging procedure of the liver which uses a probe like an ultrasound. Information gathered from this study may help researchers learn more about how to prevent or find liver cancer in patients who are currently receiving care at the HOPE clinic. Early detection of liver cancer may improve survival.
Official title: Patient-Centered Liver Cancer Prevention in the Houston Community Screening for Predictors of Fibrosis and Cirrhosis
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1000
Start Date
2020-12-22
Completion Date
2026-08-31
Last Updated
2025-10-14
Healthy Volunteers
No
Interventions
Clinical Evaluation
Undergo clinical evaluation
Laboratory Biomarker Analysis
Correlative studies
Liver Ultrasonographic Elastography
Undergo fibroscan
Survey Administration
Complete survey
Locations (1)
M D Anderson Cancer Center
Houston, Texas, United States